Resident T Cell Activation Leads to Human Hair Follicle Immune Privilege Loss Ex Vivo, Prevented by DHODH Inhibitor Farudodstat: Relevance for Alopecia Areata

    April 2026 in “ Figshare
    Ilaria Piccini (33003), Thomas Rouillé, Wolfgang Funk (405807), Francisco Jimenez (8017871), Alexandre Kaoukhov, C. Firth, Amos Gilhar (359650), Janin Edelkamp, Ferda Cevikbas, Marta Bertolini (564966)
    Image of study
    TLDR Farudodstat can prevent hair follicle immune damage linked to alopecia areata.
    This study explores the role of resident T cell activation in the loss of immune privilege in human hair follicles, which is linked to alopecia areata (AA). Using an ex vivo model with hair follicles from 7 healthy donors, researchers found that T cell activation led to immune privilege collapse, marked by increased MHC class I and II expression. The DHODH inhibitor farudodstat was shown to reduce T cell proliferation and MHC expression, partially preventing this collapse. These findings suggest that farudodstat could be a promising therapeutic candidate for AA by targeting T cell proliferation and preserving hair follicle immune privilege.
    Discuss this study in the Community →